Consejo Superior De Investigaciones Científicas (CSIC)
发明人:
申请号：
EP16848188.5
公开号：
EP3354266A1
申请日:
2016.09.19
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to the use of a group of compounds with a phenothiazine nucleus of general formula (I) for the treatment of diseases of the central nervous system which present synapse abnormalities, such as autism or fragile X syndrome. The compounds according to the invention intervene in the interaction of the NCS1 and Ric8 proteins involved in the process of synaptogenesis.
